The latest report by IMARC Group, titled “ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the ADME toxicology testing market segmentation. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global ADME toxicology testing market size reached US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.9% during 2024-2032.
Request a Sample Report: https://www.imarcgroup.com/adme-toxicology-testing-market/requestsample
ADME Toxicology Testing Market Trends:
The increasing prevalence of chronic diseases necessitates the development of new therapeutic drugs, thereby driving the global market. Regulatory bodies imposing stringent guidelines for drug approval further fuel the market, as compliance necessitates extensive ADME testing. Furthermore, technological advancements in in-vitro testing methods enhance the accuracy and reliability of ADME toxicology tests, fostering market growth.
Additionally, the rising adoption of high-throughput screening (HTS) techniques accelerates the drug discovery process, leading to increased demand for ADME toxicology testing. The shift towards personalized medicine also bolsters the market, as it requires meticulous ADME profiling of drugs. Besides, the growing investments in research and development by pharmaceutical companies significantly contribute to the expansion of the ADME toxicology testing market.
ADME Toxicology Testing Market Scope and Growth Analysis:
The market analysis indicates a substantial increase in demand for predictive toxicology models, which enhance early-stage drug development and reduce late-stage failures, thereby optimizing RD expenditures. Moreover, the rising focus on reducing animal testing and promoting alternative methods, such as organ-on-a-chip and 3D cell culture, broadens the market scope. The growing global incidence of various diseases and the subsequent need for effective therapeutics further necessitate extensive ADME toxicology testing, expanding the market's reach.
Additionally, the increasing number of clinical trials globally amplifies the demand for these tests. Furthermore, the advent of personalized medicine, which requires precise ADME toxicology profiling, is a significant factor in broadening the market scope. Collaborations between pharmaceutical companies and research institutions enhance the innovation landscape, driving market growth. The continuous evolution of regulatory frameworks to ensure drug safety and efficacy also acts as a catalyst, encouraging the adoption of comprehensive ADME toxicology testing methods.
View Full Report with TOC List of Figure: https://www.imarcgroup.com/adme-toxicology-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Agilent Technologies Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- Bioivt LLC
- Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc.
- Cyprotex Plc (Evotec AG)
- Molecular Discovery Ltd.
- Perkinelmer Inc.
- Promega Corporation
- Thermo Fisher Scientific, Inc.
ADME Toxicology Testing Market Segmentation:
Our report has categorized the market based on technology, product type, method, and application.
Breakup by Technology:
- Cell Culture
- High Throughput Screening
- Molecular Imaging
- OMICS Technology
- Others
Breakup by Product Type:
- Instruments
- Software Solutions
- Assay Systems
- Reagents
- Others
Breakup by Method:
- In-Vivo
- In-Vitro
- In-Silica
- Others
Breakup by Application:
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)
- Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
- Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About US:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
